Navigation Links
NewYork-Presbyterian/Weill Cornell creates world-class cancer center
Date:2/5/2008

NEW YORK (Feb. 5, 2008) -- NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created an expanded cancer program dedicated to advancing research, prevention and treatment of the disease. The new Cancer Center is led by renowned cancer physician-scientist Dr. Andrew Dannenberg.

A joint initiative of Weill Cornell Medical College and NewYork-Presbyterian Hospital, the Center will create strengthened and expanded research programs and multidisciplinary collaborations.

"This bold initiative will build on our strengths to create a cancer center dedicated to improving the diagnosis and treatment of patients," says Dr. Antonio M. Gotto, Jr., the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College. "By our commitment to advancing cancer research from bench to bedside, we will fulfill our mission of unlocking scientific and medical discoveries to improve lives around the globe."

"Our goal is to transform what is already an excellent cancer program into a renowned cancer center, investing in areas where we have historic strength -- such as lymphoma, lung cancer, genitourinary and preventive oncology -- while establishing new programs that can be uniquely identified with NewYork-Presbyterian/Weill Cornell," says Dr. Herbert Pardes, president and CEO of NewYork-Presbyterian Hospital.

"Cancer is the second leading cause of death in the U.S. While scientific progress continues, close to 1.5 million people will be diagnosed this year. Many of these cases will be found after the cancer has spread to other parts of the body. New ideas are desperately needed to understand why cancers form, grow and spread and how to contain them, predict them and ultimately prevent them," says Dr. David P. Hajjar, senior executive vice dean and executive vice provost of Weill Cornell Medical College and dean of Weill Cornell's Graduate School of Medical Sciences.

In conjunction with this new Center, we have committed 10 new positions for the recruitment of cancer biologists, adds Dr. Hajjar.

"The key to the success of this initiative will be collaboration and team science. Our program will facilitate interactions between physicians and scientists from a wide variety of fields -- everything from hematology and oncology to radiology, surgery, urology, genetics, pediatrics, immunology, pharmacology, even communication sciences -- helping them to create synergies that might not otherwise exist," says Dr. Dannenberg, the Henry R. Erle, M.D.Roberts Family Professor of Medicine at Weill Cornell Medical College and a leading gastroenterologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

"These multidisciplinary collaborations will extend to our colleagues at Cornell University-Ithaca, Weill Cornell Medical CollegeQatar and the Methodist Hospital in Houston, Texas," he notes.

A leading authority in cancer prevention, Dr. Dannenberg has pioneered research helping to understand the link between inflammation and cancer -- and to elucidate the mechanisms by which nonsteroidal anti-inflammatory drugs such as aspirin reduce the risk of developing certain cancers. Dr. Dannenberg has held a series of leadership positions in the American Association for Cancer Research (AACR), and serves on the editorial boards of several leading basic science and clinical oncology journals.

"We also aim to improve our physical infrastructure, with additional lab space and shared resources to stimulate the advances that are so badly needed," adds Dr. Dannenberg.


'/>"/>
Contact: Lezlie Greenberg
leg2003@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
2. Weill Cornell receives $2.4 million in grants from Gates Foundation to fight tuberculosis
3. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
4. Healthy restaurants help make us fat, says a new Cornell study
5. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
6. Bobbi Brown Cosmetics Creates Limited-Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show
7. Bobbi Brown Cosmetics Creates Limited-Edition Red Lip Palette in Partnership With The Heart Truths 2008 Red Dress Collection
8. Gene That Creates Cerebral Cortex Discovered
9. National Heart Lung and Blood Institute creates national network to study cardiovascular disease
10. inVentiv Health Creates Client Development and Integration Team
11. Creative Technology Services Creates a New Operating Company Focused on Mobility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company ... with school-aged children since the holiday season. , “It happens every year around ... sharing hugs and taking photos, which is the head-to-head gateway that lice need to ...
(Date:1/20/2017)... ... ... International Protein, a company based out of Australia that focuses on developing ... trade show in Hilton Head, SC. , International Protein was founded by Christine ... of products that would elevate her fitness regime. At this ECRM trade show, Envall ...
(Date:1/20/2017)... California (PRWEB) , ... January 20, 2017 , ... "TransFlare ... to use inside of Final Cut Pro X," said Christina Austin - CEO of ... the RED Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Mary Magdalene: Grace ... mysterious life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is ... who spent her career as an educator interacting with countless women who had little ...
(Date:1/20/2017)... ... ... account following a man who went on to support his country and serve the Lord. ... Haven, Florida and at the age of 5, his family moved to Pensacola Florida. In ... and got married right out of boot camp. , He and his wife raised ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 20, 2017 ResMed (NYSE: RMD ), BMC ... Winter Haven, Florida ) today announced they have agreed on ... 3B will be permitted to sell their existing products in exchange ... settlement payment to 3B to close the Florida ... an admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... 20, 2017  Today, during a plenary ... Pathways in Immunology, Growth Disorders and Cancer," ... INFI ) presented preclinical data for ... selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical data showed ... resistance to checkpoint inhibition by remodeling the ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal ... report to their offering. ... The global clinical laboratory testing market is expected ... innovative solutions on the grounds of maximum efficiency and minimum error ...
Breaking Medicine Technology: